A Phase II Study of Erlotinib (Tarceva) in Combination with Bexarotene (Targretin) in Chemorefractory Patients with Advanced Non-small Cell Lung Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Bexarotene (Primary) ; Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms BATTLE
- 11 Aug 2017 Planned End Date changed from 1 Nov 2015 to 1 Nov 2019.
- 11 Aug 2017 Planned primary completion date changed from 1 Nov 2018 to 1 Nov 2019.
- 19 Sep 2016 Planned primary completion date changed from 1 Nov 2017 to 1 Nov 2018.